Drugmakers, insurers, hospitals, pharmacies, medical devices, clinical updates, and healthcare business leaders.
CVS Health and Aetna say they helped equip students at Branches Florida City with backpacks, school materials, and personal-care items as families prepare for the start of the school year.
THE APEX TIMES
THE APEX TIMES
A fresh round of broker notes highlighted a bullish turn for Moderna, while Baidu took a hit, underscoring how quickly sentiment can swing across sectors on Wall Street.
THE APEX TIMES
Moderna’s stock jumped sharply Tuesday after Yahoo Finance highlighted a cancer-related development seen by investors as a potential step beyond the company’s COVID-19 business.
THE APEX TIMES
A single Phase 3 readout drove an outsized jump in Moderna’s stock, with Merck also moving higher, as investors weighed whether personalized mRNA approaches can deliver durable clinical benefit in melanoma.
THE APEX TIMES
A basket of stocks gained Wednesday as traders looked for fresh outlines from the Federal Reserve, according to a Yahoo Finance market recap. Moderna surged sharply and Merck also rose after company updates mentioned in the report.
THE APEX TIMES
U.S. stocks edged higher as investors looked ahead to Federal Reserve minutes. Moderna shares jumped on reported cancer-drug news, while other tech-linked names moved on separate company-specific catalysts.
THE APEX TIMES
A clinical-stage radiopharmaceutical startup with no product revenue has drawn interest from three of pharma’s biggest acquirers. Analysts point to the kind of rights structure embedded in a Lilly partnership as a key driver of why large drugmakers would move.
THE APEX TIMES
A public market fight over obesity treatments is expanding beyond injections, as Eli Lilly and Novo Nordisk compete to capture demand for oral weight-loss drugs and defend their broader positions in the obesity market.
THE APEX TIMES
Investor focus swung to Moderna’s cancer vaccine program after a late-stage trial reported a positive outcome in melanoma patients, lifting Moderna sharply and also pushing up Merck shares.
